Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bausch Health Companies (TSE:BHC)
TSX:BHC
Holding TSE:BHC?
Track your performance easily
Earnings Data
Report Date
Feb 19, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
1.59Last Year’s EPS
1.31Same Quarter Last Year
Based on 5 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 06, 2018
|% Change Since: -5.36%
|Next Earnings Date:Aug 07, 2018
Earnings Call Sentiment|Positive
The earnings call reflected a strong quarter for Bausch Health with significant revenue and EBITDA growth, leading to an increase in full-year guidance. The company showcased robust performance in international and Solta segments, along with continued growth opportunities for XIFAXAN. However, challenges remain due to ongoing litigation and increased operating expenses.Company Guidance
During the Bausch Health third-quarter 2024 earnings call, the company reported a 7% year-over-year revenue increase on a reported basis and an 8% growth on an organic basis, excluding Bausch + Lomb. The adjusted EBITDA also saw an approximate 9% rise compared to the previous year. As a result, Bausch Health raised its full-year 2024 guidance, excluding Bausch + Lomb, across several metrics, including revenue, adjusted EBITDA, and adjusted operating cash flow. The Salix segment, particularly driven by XIFAXAN, achieved a 7% growth over the same quarter in 2023. The International segment posted an 8% organic growth, with standout performances in Canada and Latin America. Solta Medical reported a remarkable 36% organic growth year-over-year, driven by strong demand in South Korea and China. The company also highlighted its strategic priorities, including innovation through its Red Sea program, and ongoing efforts to optimize its capital structure by reducing debt and exploring options for maximizing the value of its Bausch + Lomb equity stake.Revenue and EBITDA Growth
Bausch Health excluding Bausch + Lomb reported a 7% increase in revenue on a reported basis and 8% on an organic basis. Adjusted EBITDA increased by approximately 9% compared to the prior year period.
Full Year Guidance Raised
The company raised its full-year 2024 guidance, excluding Bausch + Lomb, across multiple metrics including revenue, adjusted EBITDA, and adjusted operating cash flow.
Strong Performance in International and Solta Segments
International segment showed an 8% organic growth this quarter. Solta delivered another strong quarter with 36% organic growth year-over-year, with particular strength in South Korea and China.
XIFAXAN Growth and New Opportunities
XIFAXAN had a strong performance with 7% growth over the third quarter of 2023. New trials suggested XIFAXAN monotherapy is more effective than lactulose monotherapy in certain conditions.
---
TSE:BHC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
TSE:BHC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 30, 2024 | C$11.37 | C$12.81 | +12.66% |
| Jul 31, 2024 | C$8.26 | C$8.32 | +0.73% |
| May 02, 2024 | C$12.03 | C$11.05 | -8.15% |
| Feb 22, 2024 | C$11.69 | C$12.55 | +7.36% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Bausch Health Companies (TSE:BHC) report earnings?
Bausch Health Companies (TSE:BHC) is schdueled to report earning on Feb 19, 2025, TBA Not Confirmed.
What is Bausch Health Companies (TSE:BHC) earnings time?
Bausch Health Companies (TSE:BHC) earnings time is at Feb 19, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:BHC EPS forecast?
TSE:BHC EPS forecast for the fiscal quarter 2024 (Q4) is 1.59.
---